Tempest Delivers A Thunderbolt
Slam-dunk mid-stage data in liver cancer send TPST-1120 towards a pivotal trial, though Tempest will need both cash and a partner to fulfil the PPAR⍺ antagonist’s potential.
Slam-dunk mid-stage data in liver cancer send TPST-1120 towards a pivotal trial, though Tempest will need both cash and a partner to fulfil the PPAR⍺ antagonist’s potential.